H-D-Val-OBzl · p-tosylate

H-D-Val-OBzl · p-tosylate is a protected valine derivative presented as the benzyl ester with a p-toluenesulfonate counterion, featuring the L-valine stereocenter and a benzylic ester linkage that masks the carboxylate while retaining the amino functionality in the form of an N-protected amino acid. The structure combines a side-chain isopropyl group characteristic of valine with an esterified carboxyl group, enabling controlled transformations at the N- and C-terminus during peptide coupling workflows. The p-toluenesulfonate salt form can influence handling and downstream activation behavior by providing a defined ionic environment for synthetic intermediates. The benzyloxycarbonyl-equivalent ester motif and the N-acetylated/amide-compatible amino state make the compound suitable for stepwise amino acid derivatization, peptide building block preparation, and chiral intermediate strategies in both research and process chemistry contexts.

1. Protected Amino Acid Synthesis

H-D-Val-OBzl · p-tosylate serves as a protected amino acid ester intermediate for protected amino acid synthesis and peptide building block preparation. The benzyl ester protects the C-terminus while the N-protected valine framework positions the amino group for peptide coupling chemistry without competing carboxyl reactivity. The stereochemically defined L-valine center supports stereocontrolled incorporation into oligopeptides and peptidomimetic scaffolds, where retention of configuration is typically required for consistent structure-function relationships. The p-tosylate counterion can be leveraged in synthetic planning to maintain manageable salt/solid-state properties during intermediate handling. Downstream, the benzyl ester can be converted to activated carboxy derivatives or transformed into carboxylate forms compatible with standard peptide coupling sequences.

2. Peptide Coupling Chemistry

H-D-Val-OBzl · p-tosylate is applicable to peptide synthesis workflows that require a valine residue with a protected carboxyl group and an amino functionality aligned for amide bond formation. The benzyl ester provides a stable C-terminal handle during iterative coupling, while the valine side-chain isopropyl group supports incorporation into sequence-defined peptides and sequence variants used in biochemical research. The N-protected amino acid architecture is compatible with common peptide coupling strategies that activate the carboxyl component of the incoming partner, enabling controlled N-to-C bond construction. The salt form may assist in reproducible intermediate preparation and weighing/charging behavior in synthetic operations where amino acid derivatives are handled as solids. Resulting valine-containing peptide fragments can be extended to longer chains, enabling systematic studies of peptide conformation, stability, and residue-specific effects.

3. Side-Chain Functionalization

H-D-Val-OBzl · p-tosylate supports side-chain functionalization strategies in amino acid derivatization and molecular scaffold diversification. The valine isopropyl side chain can be used as a hydrophobic anchor in peptidomimetic design, while the protected amino acid ester allows orthogonal functional group manipulations at the termini without disturbing the side chain. The benzyl ester and N-protected state enable selective transformations that generate downstream intermediates for further conjugation, such as converting the ester-protected carboxyl into activated acids or coupling partners after side-chain modification planning. The stereodefined amino acid backbone helps maintain consistent spatial presentation of the side chain during subsequent assembly of analogs for structure-activity relationship studies. This makes the compound suitable for generating functionalized valine derivatives used in chemical biology probes, peptide analog libraries, and synthetic organic chemistry intermediate preparation.

4. Bioconjugation Linker Intermediate

H-D-Val-OBzl · p-tosylate can be employed as a chiral amino acid-based intermediate for bioconjugation chemistry where controlled amide formation and defined linker architecture are required. The protected carboxylate as a benzyl ester and the N-protected amino acid framework allow stepwise construction of amide-linked conjugates while minimizing undesired hydrolysis or side reactions during coupling setup. The p-tosylate counterion provides a practical salt form that can be integrated into synthetic routes for generating activated carboxyl derivatives or coupling-ready amino acid fragments. The valine stereocenter contributes to stereochemically consistent conjugate structures, which can matter for biomolecule recognition, enzymatic processing, or analytical characterization of conjugates. Downstream products can serve as intermediates for attaching amino acid motifs to peptides, proteins, or other biomolecular scaffolds used in biochemical research and analytical method development.

5. Pharmaceutical Intermediate Preparation

H-D-Val-OBzl · p-tosylate is relevant to pharmaceutical intermediate preparation in the context of manufacturing routes that rely on protected amino acid esters and controlled stereochemical building blocks. The compound's benzyl ester and N-protected amino acid structure align with common process chemistry strategies that separate protection, coupling, and deprotection steps to manage reactivity across multi-step syntheses. The defined L-valine stereochemistry supports reliable incorporation into peptide-like intermediates, peptidomimetic fragments, or chiral intermediates used in fine chemical production. The p-tosylate salt form can be integrated into solid handling and intermediate isolation steps typical of industrial amino acid derivative manufacturing. Resulting intermediates can be converted into carboxylic acid forms, activated coupling species, or further protected derivatives for downstream synthesis of complex chiral molecules.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis